Omega Healthcare Investors Q3 2026 earnings

OHI · 2026-11-03 16:16 AMC ET · 8-K on SEC · 10-Q on SEC

Strong quarter with record investment activity and leverage reduction, driving a 6.3% year-over-year increase in FAD per share.

Headline numbers

MetricActualYoYQoQ8-K location
EPS (GAAP)$0.27+54.2%-77.0%Ex. 99.1, income statement
EPS (adjusted)$0.81+3.8%-69.0%Ex. 99.1, income statement
Adj. EBITDA$262.1M+8.0%+0.2%Ex. 99.1, income statement
Adj. EBITDA margin77.0%+1.2 pp+0.1 ppEx. 99.1, income statement

Revenue breakdown

not stated in the 8-K

Margins and costs

  • Gross margin 77.0% (prior 75.8%, change +1.2 pp)
  • Operating expenses $263.8M (+58.4% YoY)
  • One-offs in the quarter Impairment on real estate properties $11.4M; Acquisition, merger and transition related costs $59.9M; Severance expense $18.8M; Loss on debt extinguishment $0.0M
  • Effective tax rate 3.3% (prior-year 2.3%, year-to-date 2.0%)
  • Non-GAAP bridge Adds back acquisition, merger and transition related costs, severance expense, stock-based compensation, straight-line rent and other write-offs, loss on debt extinguishment, non-cash (recovery) provision for credit losses, and other normalizing items.

KPIs

MetricActualPrior quarterPrior yearChange
FAD per share$0.78$0.82$0.73+6.8% YoY
Total investments (YTD)$1.5B$1.26B$1.09B+38.5% YoY
Total investments (Q3)$1.67B$0.11B$0.10B+1,570% YoY
Total debt$4.02B$4.02B$4.01B+0.2% YoY
Debt to capitalization41.2%41.4%41.3%-0.2 pp YoY

Guidance

MetricGuidePrior guideChange
AFFO per share$3.29$3.24+5 cents
Total investments (full year)$1.5B$1.3B+$200M

What drove it

  • Revenue story Total revenues increased 9.3% year-over-year, driven by a 3.2% decrease in rental income partially offset by increases in real estate loans interest income (+0.8%), non-real estate loans interest income (-26.1%), and resident fees and services (+1,425%).
  • EPS story The increase in adjusted EPS came primarily from higher adjusted funds from operations (AFFO) and a lower share count.
  • One-off check Impairment on real estate properties $11.4M; Acquisition, merger and transition related costs $59.9M; Severance expense $18.8M; Loss on debt extinguishment $0.0M.

The good

  • FAD per share increased 6.3% year-over-year
  • Total investments year-to-date reached $1.5 billion
  • Debt to capitalization reduced to 41.2%, the lowest in the Company's history
  • AFFO guidance increased by 5 cents to $3.29

The bad

  • Net income and GAAP EPS declined significantly quarter-over-quarter due to a $249.1M loss on asset sales
  • Rental income decreased 3.1% year-over-year

The ugly

  • none

Open questions

  • The release does not provide a reconciliation of the $1.5 billion total investments figure to the specific components (acquisitions, loans, unconsolidated entities) for the full year.
  • The release does not provide a reconciliation of the $1.5 billion total investments figure to the specific components (acquisitions, loans, unconsolidated entities) for the full year.
Full release

Omega Healthcare Investors (OHI) earnings release, November 3, 2026

Omega Healthcare Investors Inc (OHI) · Form 8-K, Item 2.02 · Filed · SEC filing

​

PRESS RELEASE – FOR IMMEDIATE RELEASE

OMEGA REPORTS THIRD QUARTER 2026 RESULTS

AND RECENT DEVELOPMENTS

Completed $1.5 Billion in New Investments Year-to-Date, Including $946 Million Since Quarter-End

Raises Full Year 2026 Guidance

HUNT VALLEY, MARYLAND – November 3, 2026 – Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended September 30, 2026.

THIRD QUARTER 2026 AND RECENT HIGHLIGHTS

Nareit Funds From Operations (“Nareit FFO”), AFFO, FAD and NOI are supplemental non-GAAP financial measures the Company believes are useful in evaluating the performance of real estate investment trusts (“REITs”). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.

CEO COMMENTS

Matthew Gourmand, Omega’s Chief Executive Officer, stated, “We are pleased to report strong third quarter results, as we continued to grow FAD per share year over year, while reducing leverage to the lowest level in the Company’s history. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by five cents to $3.29.”

​

Mr. Gourmand continued, “The investments made in the third and early fourth quarter highlight the breadth of opportunities available to us to continue to grow shareholder value. The pipeline remains strong, and we expect to make further accretive investments through the remainder of this year and into early 2027.”

​

Mr. Gourmand concluded, “Importantly, the backdrop that has allowed us to deliver strong shareholder returns over the past few years remains in place. Operating metrics continue to be robust, with operator coverage further improving in the quarter, and we have a strong balance sheet and cost of capital that should allow us to continue to accretively invest.”

THIRD QUARTER 2026 PORTFOLIO AND RECENT ACTIVITY

Operator Updates:

PACS – On October 1, 2026, the Company transitioned 32 SNFs in Florida from Airamid Health Services, LLC (“Airamid”) to PACS and added the facilities to the Company’s existing PACS master lease. Initial annual contractual rent attributable to the facilities is $58.0 million, an increase of $26.1 million from the prior annual contractual rent on the portfolio. Annual contractual rent increases by an additional $2.5 million in year two, with 2% annual escalators thereafter through the lease’s January 31, 2038 maturity. The Company also paid Airamid a $90.0 million lease termination fee in connection with the transition, which was capitalized and will be amortized over the remaining term of the PACS lease.

Genesis – In October 2026, the Genesis Chapter 11 bankruptcy sale was finalized, resulting in the assumption and assignment of Omega’s master lease to affiliates of 101 W State Street Holdings, LLC (“NewGen”). In connection with the bankruptcy finalization, Omega received $149.5 million during October 2026 related to repayments of amounts outstanding under its DIP and term loans. During the third quarter of 2026, Omega recognized $13.3 million of rental income and $4.8 million of interest income related to Genesis.

Maplewood – In the third quarter of 2026, Maplewood Senior Living (along with affiliates “Maplewood”) paid $20.1 million in rent (compared to $19.6 million in the second quarter of 2026).

New Investments:

The following table presents investment activity:

​

​

$167 Million in Real Estate Acquisitions – In the third quarter of 2026, the Company acquired 17 facilities for $167.3 million, comprised of:

$14 Million in Real Estate Loans – In the third quarter of 2026, the Company funded $14.2 million in real estate loans, including $12.8 million (CAD 18.0 million) of additional funding under a previously disclosed Canadian development loan.

$946 Million in Q4 2026 Investment Activity – From October 1, 2026 through the date of this release, the Company completed $945.5 million of new investments, comprised of:

Other Portfolio Activity:

$48 Million in U.K. RIDEA Conversions – During the third quarter of 2026, the Company acquired the operators of 30 U.K. care homes for £35.8 million ($48.0 million) in cash and converted the facilities from triple-net leases to RIDEA structures, which will be managed by three established U.K. operators with whom the Company has existing relationships. Annual contractual rent associated with the 30 U.K. care homes prior to the conversion was £20.1 million ($26.7 million) with an EBITDAR coverage ratio of 1.47x for the trailing twelve months ended June 30, 2026. Substantially all of the purchase consideration represented payments to terminate the Company’s preexisting leases with the operators. These amounts, together with related transaction expenses, were recorded as acquisition, merger and transition related costs.

Saber PropCo JV – $88 Million in Real Estate Investments – In July 2026, SHH Holdings, LLC (“Saber PropCo JV”), a property holding company in which Omega owns a 49% equity interest, completed the acquisition of five SNFs for $87.7 million as part of the Ciena Laurels portfolio transactions previously disclosed in the second quarter of 2026. As of September 30, 2026, Saber PropCo JV owned 71 facilities leased to Saber Healthcare Holdings, LLC under triple-net leases generating annual contractual rent of $83.1 million and had $584.4 million of mortgage debt outstanding with a weighted-average interest rate of 5.2%.

Held for Sale and Impairments:

Held for Sale – At September 30, 2026, one care home with a net book value of $1.3 million was classified as held for sale.

Impairments – In the third quarter of 2026, the Company recorded an $11.4 million net impairment charge related to one facility.

TRIPLE-NET AND MORTGAGE LOAN OPERATOR COVERAGE DATA... (truncated)erified this information and is providing this data for informational purposes only. The data excludes non-core facilities, as defined in the Third Quarter 2026 Quarterly Supplement available under “Financial Info” in the Investors section of Omega’s website.

FINANCING ACTIVITIES

ATM Program and Dividend Reinvestment and Common Stock Purchase Plan – The following is a summary of the common shares issued through the third quarter of 2026:

Financial statements

Income Statement

Three Months Ended — (in thousands, except per share amounts)

Three Months Ended – September 30, – 2026Three Months Ended – September 30, – 2025Nine Months Ended – September 30, – 2026Nine Months Ended – September 30, – 2025
Revenues
Rental income252,800260,744782,394724,715
Real estate tax and ground lease income4,1853,79611,69411,205
Real estate loans interest income34,19034,421102,479100,558
Non-real estate loans interest income7,66210,39031,28430,366
Resident fees and services30,75651,400
Miscellaneous income10,9612,24012,5044,038
Total revenues340,554311,591991,755870,882
Expenses
Depreciation and amortization82,03382,114248,015242,498
Interest expense44,53958,115142,410163,292
Property-level expenses(1)29,9374,01955,57711,616
General and administrative14,24113,98543,62041,390
Stock-based compensation expense6,5649,27725,89827,721
Severance expense18,75137,6229,011
Acquisition, merger and transition related costs59,87959365,6534,067
Impairment on real estate properties11,3551,14411,74716,594
Recovery for credit losses-3,509-3,908-11,822-3,587
Total expenses263,790165,339618,720512,602
Other income (expense)
Other income – net9,08516,8352,94633,633
Loss on debt extinguishment-7-7
(Loss) gain on assets sold – net-43428,269249,10961,230
Total other income8,65145,097252,05594,856
Income before income tax expense and income (loss) from unconsolidated entities85,415191,349625,090453,136
Income tax expense-2,836-4,483-12,560-12,622
Income (loss) from unconsolidated entities4,236-1,91012,529-3,019
Net income86,815184,956625,059437,495
Net income attributable to noncontrolling interest-3,723-5,237-28,095-12,145
Net income available to common stockholders83,092179,719596,964425,350
Basic:
Net income available to common stockholders0.270.61.941.41
Diluted:
Net income available to common stockholders0.270.591.921.39
Dividends declared per common share0.680.672.022.01

Income Statement

Three Months Ended — (in thousands, except per share amounts)

Three Months Ended – September 30, – 2026Three Months Ended – September 30, – 2025Nine Months Ended – September 30, – 2026Nine Months Ended – September 30, – 2025
Net income (1)86,815184,956625,059437,495
Add back loss (deduct gain) from real estate dispositions434-28,269-249,109-61,230
Sub-total87,249156,687375,950376,265
Elimination of non-cash items included in net income:
Depreciation and amortization82,03382,114248,015242,498
Depreciation – unconsolidated entities10,8381,86529,2223,704
Impairment on real estate properties11,3551,14411,74716,594
Nareit funds from operations (“Nareit FFO”)191,475241,810664,934639,061
Weighted-average common shares outstanding, basic303,877295,827299,949290,057
Restricted stock and PRSUs2,9873,4853,1383,561
Omega OP Units14,1508,86114,3988,547
Weighted-average common shares outstanding, diluted321,014308,173317,485302,165
Nareit funds from operations available per share0.60.782.092.11
Adjustments to calculate adjusted funds from operations
Nareit FFO191,475241,810664,934639,061
Add back (deduct):
Acquisition, merger and transition related costs59,87959365,6534,067
Severance expense18,75137,6229,011
Stock-based compensation expense6,5649,27725,89827,721
Straight-line rent and other write-offs (2)4,85814,62027,537
Loss on debt extinguishment77
Non-cash (recovery) provision for credit losses-1,020-2,570-4,8511,578
Other normalizing items – net (3)-18,413-6,349-20,752-12,593
Adjusted funds from operations (“AFFO”) (1)(4)262,094242,768783,124696,389
Adjustments to calculate funds available for distribution
Non-cash expense (5)1,1191,6843,7457,621
Capitalized interest-190-98-470-929
Non-cash revenue-13,291-13,143-42,336-37,803
Funds available for distribution (“FAD”) (1)(4)249,732231,211744,063665,278

Income Statement

Three Months Ended September 30, — (in thousands)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Net income86,815184,956625,059437,495

Balance Sheet

September 30, — (in thousands, except per share amounts)

September 30, – 2026 – (Unaudited)December 31, – 2025
Real estate assets
Buildings and improvements7,866,1937,901,652
Land1,196,2221,179,463
Furniture and equipment542,504539,775
Construction in progress21,07112,492
Total real estate assets9,625,9909,633,382
Less accumulated depreciation-3,061,110-2,930,611
Real estate assets – net6,564,8806,702,771
Real estate loans receivable – net1,345,5991,380,949
Investments in unconsolidated entities494,764414,127
Assets held for sale1,2974,000
Total real estate investments8,406,5408,501,847
Non-real estate loans receivable – net254,537330,322
Total investments8,661,0778,832,169
Cash and cash equivalents195,89727,024
Restricted cash27,70827,539
Contractual and other receivables – net275,191280,774
Goodwill648,550644,626
Other assets312,850236,927
Total assets10,121,27310,049,059
LIABILITIES AND EQUITY
Revolving credit facility$—242,000
Senior notes and other unsecured borrowings – net4,020,9274,014,011
Accrued expenses and other liabilities337,279352,549
Total liabilities4,358,2064,608,560
Common stock $0.10 par value authorized – 700,000 shares, issued and outstanding – 303,854 shares as of September 30, 2026 and 295,539 shares as of December 31, 202530,38529,553
Additional paid-in capital9,047,1648,693,033
Cumulative net earnings5,274,0564,677,092
Cumulative dividends paid-8,903,042-8,297,416
Accumulated other comprehensive income57,52779,037
Total stockholders’ equity5,506,0905,181,299
Noncontrolling interest256,977259,200
Total equity5,763,0675,440,499
Total liabilities and equity10,121,27310,049,059

Cash Flow

From the 10-Q · Nine Months Ended September 30, — (in thousands)

Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Cash flows from operating activities
Net income625,059437,495
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization248,015242,498
Impairment on real estate properties11,74716,594
Straight-line rent and other write-offs25,82227,537
(Recovery) provision for credit losses-11,822-3,587
Amortization of deferred financing costs and loss on debt extinguishment10,2123,458
Stock-based compensation expense57,73734,323

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Omega Healthcare Investors earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.